Kaye Edward M. MD sold STOK
October 8, 2025 · Form 4 insider transaction
Kaye Edward M. MD sold 25,000 shares of Stoke Therapeutics, Inc. at $30.00 per share, a transaction worth $750.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
25,000
Price
$30.00
Total value
$750.0K
InsiderKaye Edward M. MD
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 8, 2025
Filing dateOctober 10, 2025
Shares owned after49,124
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2024.